Healthcare News – Read More Novo Nordisk says its potential Wegovy successor helped patients lose more weight than Zepbound in a major clinical trial.
Novo Nordisk’s next-gen weight loss drug outperforms Zepbound in new trial
HootMD curates medical news from trusted publishers. Follow the links in this article to read the full story at the original source.
